All In Biotech

NDA 020812 · Haleon US Holdings

Infant'S Advil

Ibuprofen · Oral · Nonsteroidal Anti-inflammatory Drug

Last checked: Nov 20, 2026Latest source record: Jul 6, 2017 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1998

Jan 30, 1998

Approved uses

2

Original approval plus efficacy supplements

Registered trials

910

162 Phase 3, 61 recruiting

FAERS reports

201,145

146,612 serious, 16,449 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Nov 26, 2024.

Uses temporarily: • reduces fever • relieves minor aches and pains due to the common cold, flu, headaches and toothaches

Therapeutic areas: Pain and anesthesia

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jan 12, 2000 Supplement 3 · Efficacy Label
  • Jan 30, 1998 Original approval · Type 3 - New Dosage Form Review
2 products under this application
  • INFANT'S ADVIL · IBUPROFEN 50MG/1.25ML · SUSPENSION/DROPS, ORAL · Over-the-counter
  • PEDIATRIC ADVIL · IBUPROFEN 100MG/2.5ML · SUSPENSION/DROPS, ORAL · Discontinued

Clinical trials

Interventional ClinicalTrials.gov studies with "Ibuprofen" as an intervention, any sponsor and status, largest first.

All 910 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective15,929
  • pain15,215
  • fatigue14,694
  • nausea13,725
  • headache12,240
  • arthralgia11,062
  • dyspnoea10,659
  • vomiting10,122
  • diarrhoea9,836
  • rash9,144
  • off label use8,772
  • dizziness8,294

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20041,609
20052,142
20062,049
20072,109
20081,779
20092,763
20103,972
20115,692
20127,047
20136,749
20146,565
20159,097
201612,496
201711,343
201815,594
201916,678
202015,479
202115,249
202214,644
202313,671
202412,644
202512,811
20268,954

Recalls

1 FDA enforcement reports for this application.

  • Mar 16, 2020 · Class II · Terminated

    Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 2,680 on PubMed

Sponsor: Haleon US Holdings · Also marketed as Pediatric Advil

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.